Uson Junior, Pedro Luiz Serrano
DeLeon, Thomas T.
Bogenberger, James M.
Pai, Rish K.
Kosiorek, Heidi E.
Yin, Jun
Ahn, Daniel H.
Sonbol, Mohammad Bassam
Bekaii-Saab, Tanios
Mansfield, Aaron S.
Buetow, Kenneth
Gores, Gregory J.
Smoot, Rory
Vasmatzis, George
Kipp, Benjamin R.
Mahipal, Amit
Baker, Alexander T.
Babiker, Hani
Barro, Oumar
Dumbauld, Chelsae
Zhou, Yumei
Aslam, Faaiq N.
Barrett, Michael
Jacobs, Bertram
Meurice, Nathalie
Arora, Mansi
Petit, Joachim
Elliott, Natalie
Nagalo, Bolni
Salomao, Marcela A.
Borad, Mitesh J. http://orcid.org/0000-0003-2700-2658
Funding for this research was provided by:
National Institutes of Health (DP2 Award CA195764)
National Cancer Institute (K12 award CA090628, K01 award CA234324)
SPORE (SPORE Project Award 5P50CA210964-03, SPORE Supplement Award 3P50CA210964-02S1)
Article History
Received: 6 September 2021
Accepted: 21 October 2021
First Online: 13 November 2021
Declarations
:
: This study was done in collaboration with Five Prime Therapeutics Inc. MJB has received grant to institution from Senhwa Pharmaceuticals, Adaptimmune, Agios Pharmaceuticals, Halozyme Pharmaceuticals, Five Prime Pharmaceuticals, Celgene Pharmaceuticals, EMD Merck Serono, Toray, Dicerna, Taiho Pharmaceuticals, Sun Biopharma, Isis Pharmaceuticals, Redhill Pharmaceuticals, Boston Biomed, Basilea, Incyte Pharmaceuticals, Mirna Pharmaceuticals, Medimmune, Bioline, Sillajen, ARIAD Pharmaceuticals, PUMA Pharmaceuticals, Novartis Pharmaceuticals, QED Pharmaceuticals, Pieris Pharmaceuticals, consultancy from ADC Therapeutics, Exelixis Pharmaceuticals, Inspyr Therapeutics, G1 Therapeutics, Immunovative Therapies, OncBioMune Pharmaceuticals, Western Oncolytics, Lynx Group, and travel support from Astra Zeneca. JMB and MJB have received bemarituzumab under a Material Transfer Agreement with Five Prime Therapeutics Inc. to facilitate ongoing preclinical studies. The remaining authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript.